Navigation Links
CODA Genomics Announces Issuance of Optimized Synthetic Gene Production Patent
Date:9/4/2007

LAGUNA HILLS, Calif., Sept. 4 /PRNewswire/ -- CODA Genomics, Inc., a pioneer in applying its namesake technology, (Computational Optimized DNA Assembly) towards the manufacture of synthetic genes and other DNA fragments, announced today that the US Patent and Trademark Office has issued US Patent 7,262,031 to its two founding scientists, University of California, Irvine (UCI) professors, Richard H. Lathrop and G. Wesley Hatfield. The technology was developed under a prestigious Information Technology Research grant from the National Science Foundation jointly in the School of Medicine and the Donald Bren School of Information and Computer Sciences at UCI. The Company has licensed this patent exclusively from the UCI's Office of Technology Assessment (OTA).

US Patent 7,262,031 entitled, "Method for Producing a Synthetic Gene or Other DNA Sequence," teaches how to use a global (across all possible correct and incorrect gene assemblies) optimization method for the choice of DNA code to make a given protein. Properly chosen DNA enables the thermodynamically controlled self-assembly of only the desired DNA product(s). The synthetic gene is simultaneously optimized for many other parameters that affect the successful use of the gene to make protein efficiently in any desired biological system.

Dr. Robert J Molinari, Ph.D., CODA's CEO said, "This broad protection of CODA's breakthrough technology will allow the company to aggressively market its high-yielding Hot-RodTM genes, and other optimized gene variant sets. For the customer, it allows a scaleable way to test a large number of gene and protein variants for desirable properties."

David Schetter, assistant Vice-chancellor, Research and Technology Alliances, at UCI adds "CODA has been one of UCI's first, successful examples of OTA's "Virtual Incubation" model where early stage technology is licensed to a start-up company and the technology is incubated in the University by way of a series of standard agreements for research, technology development and access to UCI's facilities and equipment. All of these agreements are negotiated at arm's length and meet the university's standards for proper use of university facilities and mitigation of conflicts of interest. As a result, the University gains additional resources and a role in ensuring the success of the technology while the company does not incur premature and expensive spin-out costs. Additionally, with more well developed and proven technology, the company is better able to raise required capital to move to its non-virtual stage."

About CODA Genomics, Inc.

CODA Genomics, Inc. is a protein Translation Engineering company focused on proprietary patented approaches to express proteins in a variety of organisms. This unique technology enables synthetic biology to solve many protein expression problems. For more CODA information, visit http://www.codagenomics.com.


'/>"/>
SOURCE CODA Genomics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. The DIG System Nonradioactive Automated High-Throughput In Situ Hybridization: a Powerful Tool for Functional Genomics Research
2. Genomics researcher Hood joins NimbleGen board
3. GE Healthcare partners with genomics institute
4. Speaker announces business members of IT Task Force
5. Doyle announces technology tax credits for Berbee
6. Doyle announces new energy, global warming policies
7. Doyle announces $80M renewable energy strategy
8. GE announces first installation of Discovery VCT
9. UWM announces winners of RGI awards
10. Third Wave announces two senior management appointments
11. Mirus announces new method for making antibodies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)...  Global demand for enzymes is forecast to ... $7.2 billion.  This market includes enzymes used in ... production, animal feed, and other markets) and specialty ... and beverages will remain the largest market for ... products containing enzymes in developing regions.  These and ...
(Date:6/27/2016)... ... 2016 , ... Parallel 6 , the leading software as a service ... Virtual Patient Encounter CONSULT module which enables both audio and video telemedicine communication ... , Using the CONSULT module, patients and physicians can schedule a face to face ...
(Date:6/27/2016)... --  Ginkgo Bioworks , a leading organism design ... awarded as one of the World Economic Forum,s ... innovative companies. Ginkgo Bioworks is engineering biology to ... in the nutrition, health and consumer goods sectors. ... including Fortune 500 companies to design microbes for ...
(Date:6/24/2016)... ... , ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical ... mesothelioma. Their findings are the subject of a new article on the Surviving Mesothelioma ... in the blood, lung fluid or tissue of mesothelioma patients that can help point ...
Breaking Biology Technology:
(Date:6/2/2016)... June 2, 2016 Perimeter Surveillance ... Unmanned Systems, Physical Infrastructure, Support & Other Service  ... visiongain offers comprehensive analysis of the global ... will generate revenues of $17.98 billion in 2016. ... Inc, a leader in software and hardware technologies for ...
(Date:5/20/2016)... 2016  VoiceIt is excited to announce its ... By working together, VoiceIt and VoicePass will ... VoicePass take slightly different approaches to voice biometrics, ... and usability. ... partnership. "This marketing and technology partnership ...
(Date:5/9/2016)... UAE, May 9, 2016 Elevay ... comes to expanding freedom for high net worth professionals ... in today,s globally connected world, there is still no ... could ever duplicate sealing your deal with a firm ... passports by taking advantage of citizenship via investment programs ...
Breaking Biology News(10 mins):